The Potential Rise in the Price of Protalix BioTherapeutics Inc (PLX) following insiders activity
Taking this into account, H.C. Wainwright reiterated its Protalix BioTherapeutics Inc [PLX] rating to a Buy in a research note
Taking this into account, H.C. Wainwright reiterated its Protalix BioTherapeutics Inc [PLX] rating to a Buy in a research note
As published in a research note from H.C. Wainwright on June 08, 2020, Protalix BioTherapeutics Inc [PLX] has been retained
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.